The Czech Republic Digestive System Disorder Medicine Sales is set to reach $654.4 Million by 2026 from $587.7 Million, is expected to be up 5.2% per year. Since 2017, the market was up 3.9% year on year to $36,680 Million. Japan, South Korea and Canada respectively ranked numbers 2, 3 and 4 in this ranking.